###begin article-title 0
The calcium-sensing receptor regulates parathyroid hormone gene expression in transfected HEK293 cells
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 141 144 141 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 178 181 178 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 227 235 227 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 330 335 330 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 365 369 365 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis </italic>
###xml 703 708 <span type="species:ncbi:9606">human</span>
###xml 742 747 <span type="species:ncbi:9606">human</span>
The parathyroid calcium receptor determines parathyroid hormone secretion and the response of parathyroid hormone gene expression to serum Ca2+ in the parathyroid gland. Serum Ca2+ regulates parathyroid hormone gene expression in vivo post-transcriptionally affecting parathyroid hormone mRNA stability through the interaction of trans-acting proteins to a defined cis element in the parathyroid hormone mRNA 3'-untranslated region. These parathyroid hormone mRNA binding proteins include AUF1 which stabilizes and KSRP which destabilizes the parathyroid hormone mRNA. There is no parathyroid cell line; therefore, we developed a parathyroid engineered cell using expression vectors for the full-length human parathyroid hormone gene and the human calcium receptor.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 343 351 343 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 389 393 389 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis </italic>
###xml 467 470 467 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 849 857 849 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 23 28 <span type="species:ncbi:9606">human</span>
###xml 54 59 <span type="species:ncbi:9606">human</span>
Co-transfection of the human calcium receptor and the human parathyroid hormone plasmid into HEK293 cells decreased parathyroid hormone mRNA levels and secreted parathyroid hormone compared with cells that do not express the calcium receptor. The decreased parathyroid hormone mRNA correlated with decreased parathyroid hormone mRNA stability in vitro, which was dependent upon the 3'-UTR cis element. Moreover, parathyroid hormone gene expression was regulated by Ca2+ and the calcimimetic R568, in cells co-transfected with the calcium receptor but not in cells without the calcium receptor. RNA immunoprecipitation analysis in calcium receptor-transfected cells showed increased KSRP-parathyroid hormone mRNA binding and decreased binding to AUF1. The calcium receptor led to post-translational modifications in AUF1 as occurs in the parathyroid in vivo after activation of the calcium receptor.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 283 287 283 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis </italic>
###xml 332 337 332 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 401 409 401 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
The expression of the calcium receptor is sufficient to confer the regulation of parathyroid hormone gene expression to these heterologous cells. The calcium receptor decreases parathyroid hormone gene expression in these engineered cells through the parathyroid hormone mRNA 3'-UTR cis element and the balanced interactions of the trans-acting factors KSRP and AUF1 with parathyroid hormone mRNA, as in vivo in the parathyroid. This is the first demonstration that the calcium receptor can regulate parathyroid hormone gene expression in heterologous cells.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 104 107 104 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 111 113 111 113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 114 115 114 115 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o</sub>
###xml 189 190 189 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 250 252 250 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 253 255 253 255 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 362 364 362 364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 365 367 365 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 646 647 646 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 648 649 648 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 751 752 751 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 753 754 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 778 783 778 783 <sub xmlns:xlink="http://www.w3.org/1999/xlink">q/11 </sub>
###xml 858 859 858 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 873 876 873 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CaR</italic>
###xml 876 880 876 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 923 925 923 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 961 964 961 964 <italic xmlns:xlink="http://www.w3.org/1999/xlink">PTH</italic>
###xml 964 968 964 968 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 971 975 971 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GCM2</italic>
###xml 975 979 975 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1033 1035 1033 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1036 1038 1036 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1181 1184 1181 1184 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 880 884 <span type="species:ncbi:10090">mice</span>
###xml 979 983 <span type="species:ncbi:10090">mice</span>
Parathyroid hormone (PTH) regulates calcium homeostasis and bone metabolism. Changes in extracellular Ca2+ ([Ca2+]o) are sensed by the parathyroid G-protein coupled calcium receptor (CaR) [1]. The CaR determines the response of the parathyroid to [Ca2+]o at the levels of PTH secretion, PTH gene expression and parathyroid cell proliferation [2,3]. Increased [Ca2+]o activates the CaR, resulting in a G-protein-dependent activation of PLC, PLA2 and PLD [4]. This results in decreased PTH secretion and parathyroid cell proliferation. Calcimimetics bind transmembrane (TM) 6 and TM7 of the CaR to allosterically alter the conformation of the CaR [5,6]. The calcimimetic R568 decreases PTH secretion, PTH mRNA levels and parathyroid cell proliferation [7,8]. Genetic deletion of Gq/11 specifically in the parathyroid leads to severe hyperparathyroidism (HPT) [9]. Similarly, CaR-/- mice are not viable due to the severe HPT [10] and can be rescued by mating with PTH-/- or GCM2-/- mice, where PTH is either absent or markedly reduced [11,12]. Therefore, the CaR and its signal transduction are central to parathyroid physiology and the maintenance of a normal serum PTH and intact Ca2+ homeostasis.
###end p 9
###begin p 10
###xml 12 15 12 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 184 192 184 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 254 259 254 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 289 292 289 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 585 587 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 643 647 643 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ras </italic>
###xml 666 671 666 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 713 715 713 715 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 716 718 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 917 918 917 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 919 921 919 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 922 924 922 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1134 1136 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1495 1497 1495 1497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1216 1220 <span type="species:ncbi:10116">rats</span>
###xml 1329 1333 <span type="species:ncbi:10116">rats</span>
Low serum Ca2+ and chronic kidney disease lead to secondary hyperparathyroidism which is characterized by increased PTH mRNA levels in experimental models [13]. The increased PTH mRNA in vivo is post-transcriptional and is mediated by the interaction of trans-acting proteins to a defined cis-acting AU-rich element (ARE) in the PTH mRNA 3'-untranslated region (UTR) [14-16]. A 26-nucleotide sequence within the ARE is conserved among species and is both necessary and sufficient for protein binding and the regulation of PTH mRNA stability by dietary calcium or phosphorus depletion [16,17]. AU-rich binding factor 1 (AUF1) and Upstream of N-ras (Unr) are PTH mRNA trans-acting proteins that stabilize PTH mRNA [18,19]. The binding of these proteins to the PTH mRNA 3'-UTR is regulated in the parathyroid by chronic hypocalcemia, hypophosphatemia and experimental kidney failure as well as by the calcimimetic R568 [7,15,16]. We have recently identified the decay-promoting protein KSRP (KH domain splicing regulatory protein) as an additional PTH mRNA 3'-UTR binding protein that determines PTH mRNA stability in transfected cells [20]. KSRP-PTH mRNA interaction is increased in parathyroids from hypophosphatemic rats, where PTH mRNA is unstable, and decreased in parathyroids from hypocalcemic and experimental renal failure rats, where the PTH mRNA is more stable. The balanced interaction of PTH mRNA with AUF1 and KSRP determines PTH mRNA half-life and levels and hence serum PTH levels [20].
###end p 10
###begin p 11
###xml 81 83 81 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 84 86 84 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 289 298 289 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 488 490 488 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 491 493 491 493 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 747 749 747 749 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 750 752 750 752 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 1230 1232 1230 1232 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1233 1235 1233 1235 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 1589 1597 1589 1597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1598 1599 1598 1599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1600 1602 1600 1602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 142 148 <span type="species:ncbi:9913">bovine</span>
###xml 185 188 <span type="species:ncbi:10116">rat</span>
###xml 339 345 <span type="species:ncbi:9913">bovine</span>
There is no parathyroid cell line and the signal transduction pathway whereby [Ca2+]o regulates PTH secretion has been characterized by using bovine parathyroid cells in suspension and rat parathyroid organ cultures [21,22]. Parathyroid hormone gene expression and its regulation in cells in vitro have been studied in primary cultures of bovine parathyroids [23,24]. HEK293 cells transfected with the CaR faithfully maintain an intact signal transduction after the stimulus of a high [Ca2+]o to activate the mitogen-activated protein kinase (MAPK) pathway [25,26]. We have now utilized this transfected heterologous cell system to study the mechanisms whereby the CaR regulates PTH gene expression. As the regulation of PTH gene expression by [Ca2+]o is predominantly post-transcriptional, we studied PTH mRNA stability in a system that was independent of any effect on PTH transcription through the PTH promoter. To do this we expressed PTH mRNA driven by a viral promoter to express large amounts of PTH mRNA in HEK293 cells. Differences in PTH mRNA levels would therefore represent only post-transcriptional regulation. Expression of the CaR markedly decreased PTH mRNA levels and stability and conferred responsiveness to [Ca2+]o and the calcimimetic R568 in these cells. This was mediated by the PTH mRNA 3'-UTR ARE. Moreover, expression of the CaR in the HEK293 cells led to a shift from the interaction of the PTH mRNA with the stabilizing protein, AUF1, to the destabilizing protein, KSRP. Furthermore, the expression of CaR modified AUF1 post-translationally as previously shown in vivo [7,27]. Therefore, the expression of the CaR in this heterologous cell system reproduces the signal transduction that determines PTH gene expression in the parathyroid.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
The calcium receptor decreases parathyroid hormone mRNA levels post-transcriptionally in HEK293 cells
###end title 13
###begin p 14
###xml 61 64 61 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 255 260 <span type="species:ncbi:9606">human</span>
###xml 337 341 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 357 360 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 464 467 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
PTH gene expression is regulated post-transcriptionally by Ca2+ and calcimimetics affecting PTH mRNA stability [7,15]. To focus on the effect of the CaR on PTH mRNA stability in a cell system we constructed an expression vector containing the full-length human PTH gene including its three exons and two introns (hPTH) driven by a viral SV40 (not shown) or CMV promoter (Figure 1A). Expression of PTH from both viral promoters gave similar results and we used the CMV promoter for further studies.
###end p 14
###begin p 15
###xml 0 83 0 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Over-expression of the CaR decreases PTH mRNA levels in co-transfected HEK293 cells</bold>
###xml 259 260 259 260 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 541 542 541 542 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 795 796 795 796 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 967 970 967 970 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D-G</bold>
###xml 1005 1006 1005 1006 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 1168 1169 1168 1169 <bold xmlns:xlink="http://www.w3.org/1999/xlink">E</bold>
###xml 1268 1269 1268 1269 <bold xmlns:xlink="http://www.w3.org/1999/xlink">F</bold>
###xml 1352 1354 1352 1354 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1356 1357 1356 1357 <bold xmlns:xlink="http://www.w3.org/1999/xlink">G</bold>
###xml 1523 1525 1521 1523 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 294 299 <span type="species:ncbi:9606">human</span>
###xml 376 379 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Over-expression of the CaR decreases PTH mRNA levels in co-transfected HEK293 cells. HEK293 cells were transiently co-transfected in triplicate with expression plasmids for the hPTH gene and control GFP or GH and either the CaR (CaR+) or empty vector (CaR-). A. Schematic representation of the human PTH expression plasmid used for transient transfections. The boxes show the CMV promoter (grey) and the PTH exons with the untranslated regions (UTRs) (white) and coding regions (diagonal lines). The arrows show the pre, pro and mature PTH. B. Immunohistochemistry on whole cells using an intact cell enzyme-linked immunoassay for the cell surface expression of the CaR. Untransfected (background), CaR (+) or control plasmid (-) transfected cells were analyzed using a CaR antibody or IgG (-). C. Immunoblot analysis of extracts from HEK293 cells co-transfected with expression plasmids for the CaR and myc-AUF1 as control plasmid, using anti-CaR or myc antibodies. D-G. Effect of CaR on PTH expression. D. Northern blot for hPTH and co-transfected GFP with the CaR (+) or an empty vector (-). Ethidium bromide staining of the membrane is shown as a loading control. E. qPCR for PTH and co-transfected GH mRNA levels from cells with (red) and without (blue) the CaR. F. Secreted PTH from cells as above 1 h after an incubation in fresh medium, 1 mM Ca2+. G. qRT-PCR for PTH mRNA levels from cells without and with either the CaR or the PTH1R (checkered). Data in D-G are expressed as fold change (mean +/- SE) (n = 3). *, P < 0.01, CaR: control.
###end p 15
###begin p 16
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1F</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 625 627 625 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 944 946 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 984 986 984 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 1042 1044 1042 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1E</xref>
###xml 1073 1075 1073 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1G</xref>
###xml 1174 1176 1174 1176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1F</xref>
###xml 1364 1366 1364 1366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1G</xref>
###xml 218 223 <span type="species:ncbi:9606">human</span>
###xml 825 830 <span type="species:ncbi:9606">human</span>
The hPTH expression plasmid was transiently transfected into HEK293 cells. The transcribed PTH mRNA was correctly spliced resulting in PTH mRNA of the expected size (Figure 1D). The PTH mRNA was translated into mature human PTH that was measured in the medium by radioimmunoassay (Figure 1F). We then studied the effect of the CaR on PTH mRNA levels in HEK293 cells expressing the PTH gene by transient transfection. The expression of the CaR was confirmed by immunohistochemistry on whole cells using an intact cell enzyme-linked immunoassay to determine cell surface expression [28] (Figure 1B) and by western blot (Figure 1C). Transfection efficiency was >95%, as indicated by fluorescent microscopy of the cells co-transfected with a green fluorescent protein (GFP) expression plasmid (not shown). Co-transfection of the human (h) CaR together with the hPTH plasmid resulted in a marked decrease in PTH mRNA levels by Northern blot (Figure 1D) and real time RT PCR (qPCR) (Figure 1E) corrected for co-transfected control genes GH (Figure 1E) or endogenous HPRT (Figure 1G). The decrease in PTH mRNA by the CaR was reflected in a decrease in secreted PTH at 48 h (Figure 1F). Transfection with another G protein coupled receptor (GPCR), the PTH receptor (PTH1R) had no effect on PTH mRNA levels, confirming the specificity of the CaR effect on PTH mRNA (Figure 1G).
###end p 16
###begin title 17
The calcium receptor decreases parathyroid hormone mRNA levels through the parathyroid hormone mRNA 3'-UTR AU-rich element
###end title 17
###begin p 18
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis-</italic>
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 317 320 <span type="species:ncbi:10116">rat</span>
We have previously reported that the regulation of PTH mRNA levels is dependent upon a cis-acting instability ARE in the PTH mRNA 3'-UTR [15,16,20]. We then determined if the regulation of PTH mRNA levels by the CaR is exerted through the PTH mRNA ARE, using a growth hormone (GH) reporter gene containing either the rat PTH 63 nt ARE (GH63) or a truncated non-functional PTH mRNA 40 nt element [29]. Over-expression of the CaR decreased GH63 mRNA levels but had no effect on wild-type GH mRNA levels or on a GH mRNA with the truncated 40 nt PTH mRNA ARE (Figure 2A). Our results indicate that the CaR specifically decreases PTH mRNA levels through the PTH mRNA ARE.
###end p 18
###begin p 19
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis </italic>
###xml 0 87 0 87 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The CaR decreases PTH mRNA levels and stability through the PTH mRNA 3'-UTR <italic>cis </italic>element</bold>
###xml 89 90 89 90 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 562 564 560 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 572 573 570 571 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 813 814 811 812 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 951 953 947 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
The CaR decreases PTH mRNA levels and stability through the PTH mRNA 3'-UTR cis element. A. Effect of CaR over-expression on reporter GH mRNA containing the PTH mRNA ARE. qRT-PCR for GH and control HPRT mRNA levels in cells transfected with either control (CaR-) or CaR (CaR+) and expression plasmids for GH (left panel), GH containing the PTH mRNA 63 nt ARE (GH-PTH63) (middle panel) or GH containing a 40 nt truncated ARE (GH-tPTH40) (right panel). Results are fold changes compared with cells without the CaR expressed as mean +/- SE of three experiments. *, P < 0.05. B. Effect of CaR on PTH mRNA decay. Representative IVDA of transcripts for the full-length hPTH mRNA and the PTH mRNA with an internal deletion of the 3'-UTR ARE, incubated with extracts from cells expressing either the CaR or empty vector. C. Quantification of the amount of intact transcripts remaining with time related to time 0 (mean +/- SE, in three repeat experiments; *, P < 0.05). Blue square, full length PTH mRNA without CaR (CaR-) and red square, with CaR (CaR+); blue triangle, PTH w/o ARE without CaR (CaR-) and red triangle, with the CaR, (CaR+).
###end p 19
###begin p 20
###xml 64 73 64 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 102 104 102 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 137 145 137 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 431 439 431 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 440 442 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 443 445 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 652 654 652 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 778 780 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 981 983 981 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 988 990 988 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
To study the effect of the CaR on PTH mRNA stability we used an in vitro degradation assay (IVDA) [16,20]. A radiolabeled polyadenylated in vitro-transcribed hPTH mRNA was incubated with extracts from cells transfected with either the CaR expression plasmid or a control plasmid. The amount of intact PTH mRNA remaining with time represents the decay of the transcript by the different extracts and is indicative of the decay rate in vivo [15,30]. The rate of PTH mRNA decay was increased by extracts from cells expressing the CaR compared with extracts from cells with control plasmid correlating with PTH mRNA levels in the transfected cells (Figure 2B, top gel and Figure 2C). We then performed IVDA using polyadenylated PTH mRNA with an internal deletion of the ARE (Figure 2B, bottom gel and Figure 2C). The PTH mRNA transcript lacking the ARE was stable throughout the experiment and in contrast to the full-length PTH mRNA, was not affected by expression of the CaR (Figure 2B and 2C). Our results indicate that the CaR specifically decreases steady-state PTH mRNA levels and PTH mRNA stability through the PTH mRNA ARE.
###end p 20
###begin title 21
Protein-PTH mRNA interactions by RNA immunoprecipitation assays
###end title 21
###begin p 22
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
###xml 131 133 131 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 582 584 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 603 609 603 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D, 1E</xref>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1G</xref>
###xml 756 758 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 847 849 847 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 977 979 977 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 980 982 980 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 15 18 <span type="species:ncbi:10116">rat</span>
In vivo in the rat parathyroid, PTH mRNA stability is determined by the regulated binding of AUF1 and KSRP to the PTH mRNA 3'-UTR [20]. To identify protein-mRNA interactions in the CaR transfected cells, we performed RNA immunoprecipitation (RIP) assays using extracts from HEK293 cells transfected with the CaR or control plasmids. Immunoprecipitation was performed with antibodies to AUF1, KSRP or control IgG followed by qRT PCR of the recovered RNA and input extracts. Parathyroid hormone mRNA was decreased in the CaR expressing extracts compared with control extracts (Figure 3A) as above (Figure 1D, 1E and 1G). The RIP assay showed that the amount of PTH mRNA bound to AUF1 was decreased in CaR-expressing cells compared with control cells (Figure 3B). In contrast, PTH mRNA bound to KSRP was increased in the CaR-expressing cells (Figure 3C). This binding pattern is consistent with the stabilizing function of AUF1 and the destabilizing function of KSRP on PTH mRNA [18,20]. The increased binding to KSRP and the decreased binding to AUF1 correlate with the lower levels of PTH mRNA induced by the CaR in the transfected cells.
###end p 22
###begin p 23
###xml 0 101 0 101 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of the CaR in HEK293 cells decreases AUF1 and increases KSRP interaction with the PTH mRNA</bold>
###xml 372 376 372 376 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(A) </bold>
###xml 400 407 400 407 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(B, C) </bold>
###xml 659 661 657 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Expression of the CaR in HEK293 cells decreases AUF1 and increases KSRP interaction with the PTH mRNA. RNA immunoprecipitation (RIP) analysis of extracts from cells transiently transfected with expression plasmids for PTH and GH as control and either the CaR plasmid or empty vector. Immunoprecipitation was performed using antibodies for AUF1, KSRP or control IgG. Input (A) and immunoprecipitiated (B, C) samples were analyzed by qPCR for PTH and GH mRNA. Results are presented as PTH mRNA corrected for GH mRNA. PTH mRNA in the immunoprecipitated samples was corrected for PTH mRNA in the input. The results are mean +/- SE of three repeat experiments. *, P < 0.05 compared with cells transfected with empty vector (CaR-).
###end p 23
###begin title 24
The calcium receptor leads to post-translational modification of the parathyroid hormone mRNA binding protein AUF1
###end title 24
###begin p 25
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo </italic>
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 720 722 720 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
In vivo dietary-induced hypocalcemia and hypophosphatemia as well as adenine-induced renal failure and the calcimimetic R568 lead to post-translational modifications of AUF1 as shown by 2D gels [7,27]. To determine whether the effect of the CaR on PTH mRNA stability in the engineered cells involves post-translational modifications of AUF1 as it does in the parathyroid, we performed 2D gels on extracts from HEK293 cells transfected with the CaR expression plasmid or an empty vector as control. AUF1 has four isoforms of p37, p40, p42 and p45. There was no difference in AUF1 protein levels in the 1D gels between cells with and without the CaR, apart from a small decrease in p45 in the CaR-expressing cells (Figure 4A). However, 2D gels showed that endogenous AUF1 isoforms p37, p40 and p42 had a different distribution of the spots between extracts of cells with and without the CaR (Figure 4B). These results suggest that the CaR induces post-translational modifications in AUF1 in the transfected cells.
###end p 25
###begin p 26
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">AUF1 is post-translationally modified in HEK293 cells transfected with CaR</bold>
###xml 76 77 76 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 136 137 132 133 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 364 365 360 361 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 526 527 522 523 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
AUF1 is post-translationally modified in HEK293 cells transfected with CaR. A. 1D gels for AUF1 and alpha-tubulin as a loading control. B. 2D gel analysis for endogenous AUF1 in extracts from cells transiently transfected with the CaR (CaR+) plasmid or empty vector (CaR-). Molecular weight markers are shown on the right and the four AUF1 isoforms are indicated. C. 2D gel analysis of extracts from cells transiently transfected with the CaR plasmid or empty vector and the myc-AUF1 isoforms p37, p40, p42 or p45 separately. D. 2D analysis of extracts from cells transiently transfected with the CaR plasmid or empty vector and myc-AUF1p40 without and after treatment with a non-specific phosphatase (CIP). The results all represent one of two repeat experiments with similar results.
###end p 26
###begin p 27
###xml 417 419 417 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 749 751 749 751 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 752 754 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1003 1005 1003 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 870 874 <span type="species:ncbi:9913">Calf</span>
To analyze the four isoforms of AUF1 separately, we utilized myc-tagged AUF1 expression plasmids. HEK293 cells were transiently transfected with expression plasmids for myc- p37, p40, p42 or p45 isoforms of AUF1 together with the CaR or control plasmids. Cell extracts were analyzed on 2D gels with an anti-myc antibody. CaR expression led to changes in mobility of myc-AUF1 p37, p40 and also p45 but not p42 (Figure 4C). Unlike the changes in myc-AUF1 p45, endogenous AUF1 p45 was only slightly modified by CaR signaling. The change in endogenous p42 was not reflected in the myc-tagged transfected p42. The reasons for these discrepancies are not clear. AUF1 p40 undergoes reversible phosphorylation which may regulate ARE-directed mRNA turnover [31,32]. We therefore added a non-specific phosphatase to extracts from cells expressing myc-p40 with or without the CaR. Calf intestinal phosphatase (CIP) treatment of control extracts modified AUF1 to the form present in CaR-expressing extracts (Figure 4D). Treatment with CIP had no further effect on the CaR-expressing extracts. These results indicate that the CaR modifies AUF1 post-translationally and suggests that at least part of this change involves phosphorylation of isoform p40.
###end p 27
###begin title 28
###xml 52 54 52 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 55 57 55 57 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
Parathyroid hormone mRNA levels are regulated by [Ca2+]o and the calcimimetic R568 through the calcium receptor
###end title 28
###begin p 29
###xml 286 288 286 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 372 375 372 375 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 439 441 439 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 456 457 456 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 482 485 482 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 605 608 605 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
We then studied the effect of a low-calcium medium on the regulation of PTH gene expression by the CaR in the transfected cells. HEK293 cells transiently co-transfected with expression plasmids for PTH and the CaR or a control plasmid were grown in a medium with either 0.2 or 1.2 mM Ca2+. Expression of the CaR decreased PTH mRNA in cells grown in physiological 1.2 mM Ca2+ concentration by both Northern blots and qRT PCR (Figure 5A and 5B) as in Figure 1. Importantly, the low-Ca2+ medium attenuated the decrease in PTH mRNA levels induced by the CaR (Figure 5A and 5B). There was no effect of a low-Ca2+ medium in cells that did not express the CaR.
###end p 29
###begin p 30
###xml 85 87 85 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 88 90 88 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 0 115 0 115 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Expression of the CaR decreases PTH mRNA levels and confers responsivity to a low [Ca<sup>2+</sup>]<sub>o </sub>and the calcimimetic R568</bold>
###xml 117 118 117 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 327 330 327 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 432 433 432 433 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 516 517 516 517 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 652 655 652 655 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 804 805 804 805 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 1171 1173 1169 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1196 1198 1194 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Expression of the CaR decreases PTH mRNA levels and confers responsivity to a low [Ca2+]o and the calcimimetic R568. A. Representative Northern blot analysis for PTH mRNA in cells transiently transfected in triplicate with hPTH and either the CaR plasmid or empty vector. After transfection cells were grown in 1.2 or 0.2 mM Ca2+ medium for an additional 48 h. Ethidium bromide staining of the membrane is shown as loading control. B. qRT PCR for PTH corrected for co-transfected GH mRNAs for cells treated as in A. C. qPCR for PTH and HPRT mRNAs from cells expressing the hPTH gene and the CaR (CaR+) or empty vector (CaR-) in cells grown in 1.2 mM Ca2+ supplemented with either R568 or vehicle. The results in A-C represent one of three repeat experiments performed in triplicate with similar results. D. Representative Northern blot for PTH and GFP mRNA levels in cells transfected with PTH and GFP and either CaR (CaR+) or empty vector (CaR-). The cells were grown in 0.2 mM calcium supplemented with R568 or vehicle. Quantification of the results is shown below the gel. The results are presented as mean +/- SE of two repeat experiments performed in triplicate. *, P < 0.05, CaR+:CaR-; **, P < 0.05, CaR+, treated:CaR+, untreated.
###end p 30
###begin p 31
###xml 60 61 60 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 151 153 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 212 215 212 215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 296 299 296 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 332 335 332 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 343 345 343 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 357 360 357 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 425 427 425 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 458 461 458 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 619 621 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 820 822 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 911 914 911 914 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 1111 1113 1111 1113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1114 1116 1114 1116 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
Calcimimetics are compounds that bind and activate the CaR [5]. We then performed the same experiments with and without the calcimimetic, R568 (Figure 4C). The CaR decreased PTH mRNA levels as before at 1.2 mM Ca2+ (Figure 5C). Activation of the CaR by R568 decreased PTH mRNA levels at 1.2 mM Ca2+ (Figure 5C) and also at 0.2 mM Ca2+ (Figure 5D). 0.2 mM Ca2+ prevented the decrease in PTH mRNA levels due to the CaR (Figure 5B and 5D). However, at 0.2 mM Ca2+ the addition of R568 still effectively decreased PTH mRNA levels (Figure 5D). There was no effect of CaR expression on co-transfected GFP mRNA levels (Figure 5D) used as a control for transfection efficiency and loading. There was also no effect of R568 on PTH mRNA levels in cells co-transfected with the control plasmid that did not express the CaR (Figure 5C and 5D). The effect of R568 on PTH mRNA levels in the CaR-transfected cells at 0.2 mM Ca2+ indicates that the calcimimetic is effective at activating the CaR even when the CaR is in a relaxed configuration. Therefore, in these engineered cells, the CaR is permissive for the effect of [Ca2+]o and R568 on PTH mRNA levels.
###end p 31
###begin title 32
Discussion
###end title 32
###begin p 33
###xml 309 311 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 428 430 428 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 431 433 431 433 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 456 458 456 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 688 690 688 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 691 693 691 693 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 714 716 714 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 792 794 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 795 797 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 798 800 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1025 1027 1025 1027 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1028 1030 1028 1030 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 1093 1101 1093 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1218 1219 1218 1219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1220 1222 1220 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1852 1861 1852 1861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 8 14 <span type="species:ncbi:9913">bovine</span>
###xml 627 633 <span type="species:ncbi:9913">bovine</span>
###xml 750 756 <span type="species:ncbi:9913">bovine</span>
Primary bovine parathyroid cells in culture have been successfully used for the study of PTH secretion in the short term (hours) but not for longer term effects on PTH gene expression. This is because these primary monolayer cultures of parathyroid cells lose the expression of the CaR after 24 h in culture [33]. Parathyroid organoid cultures retain a prolonged calcium response and regulation of PTH mRNA stability by high [Ca2+]o and a calcimimetic [34,35]. However, there is no parathyroid cell line. Kifor et al [25] showed that the CaR activated the phosphotyrosine kinase in both CaR-transfected HEK293 cells and native bovine parathyroid cells. In CaR-expressing HEK293 cells, [Ca2+]o activates PI-PLC, PLA2 and PLD, similar to the effect in bovine primary parathyroid cell cultures [25,26,36]. There have been no studies on the effect of the CaR on the regulation of PTH gene expression using the transfected HEK293 cells. We therefore expressed the CaR together with the hPTH gene in HEK293 cells. The effect of [Ca2+]o and the calcimimetic R568 on PTH expression in the parathyroid in vivo is predominantly post-transcriptional, regulating PTH mRNA stability and not transcription through the PTH promoter [7,15]. This allowed us to use a viral promoter upstream of the hPTH gene to study the effect of the CaR signaling on PTH mRNA levels. The PTH gene was efficiently transcribed, processed and translated to mature immunoreactive PTH. Significantly, PTH mRNA and secreted PTH levels were decreased in cells expressing the CaR compared with control cells. The calcium concentration in the medium was 1.2 mM, which would activate the CaR to reduce PTH mRNA levels in the CaR-transfected cells. Therefore, the CaR suppresses PTH gene expression post-transcriptionally by acting on PTH mRNA driven by a viral and not the native PTH promoter. In vitro degradation assays using extracts from cells with or without the CaR showed that expression of the CaR led to a decrease in full-length PTH mRNA half-life but not the half-life of a PTH mRNA with an internal deletion of the PTH mRNA ARE. The decreased PTH mRNA stability correlated with decreased PTH mRNA steady state levels.
###end p 33
###begin p 34
###xml 91 99 91 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 287 290 287 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 326 328 326 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
Dietary-induced changes in serum calcium and phosphate levels regulate PTH gene expression in vivo post-transcriptionally [14,15]. This regulation is mediated by the changes in binding of stabilizing trans-acting factors, AUF1 and Unr, and the destabilizing protein KSRP, to the defined cis-acting ARE in the PTH mRNA 3'-UTR [16,18-20]. The role of the PTH mRNA ARE in the regulation of PTH mRNA levels by the CaR was demonstrated by transfection experiments using a GH reporter mRNA containing the PTH mRNA 63 nt ARE. The CaR decreased GH-PTH ARE mRNA levels but had no effect on native GH mRNA or a GH mRNA containing a truncated PTH mRNA ARE. Calcium receptor-transfected HEK293 cells showed increased KSRP-PTH mRNA binding and decreased AUF1-PTH mRNA binding by RIP analysis, correlating with the decreased PTH mRNA levels and stability in the CaR-transfected cells. Therefore, the signaling of the CaR in the parathyroid is maintained in the transfected cells as reflected in changes in AUF1 and KSRP PTH mRNA interactions and the role of the PTH mRNA ARE in this regulation.
###end p 34
###begin p 35
###xml 155 156 155 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 187 190 187 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 447 448 447 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 666 674 666 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1037 1039 1037 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1340 1342 1340 1342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1343 1345 1343 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1658 1660 1658 1660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1661 1663 1661 1663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
AUF1-PTH mRNA binding is increased by hypocalcemia or chronic kidney disease, or decreased by hypophosphatemia or administration of the calcimimetic R568 [7,15]. These changes in serum Ca2+ or phosphate and kidney disease are associated with post-translational modifications of AUF1. AUF1 isoforms p40 and p42 are modified by dietary-induced hypocalcemia, and the secondary hyperparathyroidism of chronic kidney disease and its treatment by R568 [7,27]. We now show that expression of the CaR in the engineered cells also induces post-translational modifications in both endogenous AUF1 and myc-tagged transfected AUF1 isoforms that are similar to the modifications in vivo in the parathyroid. The modification of at least AUF1 p40 involves phosphorylation where expression of the CaR is associated with dephosphorylation. Post-translational modifications of this isoform, AUF1 p40, are altered concomitant with changes in RNA binding activity and stabilization of ARE-containing mRNAs in phorbol ester-treated monocytic leukemia cells [32]. AUF1 p40 recovered from polysomes was phosphorylated on Ser83 and Ser87 in untreated cells but lost these modifications following phorbol ester treatment. It was suggested that selected signal transduction pathways may regulate ARE-directed mRNA turnover by reversible phosphorylation of AUF1 p40 [31,32]. Therefore, both in the CaR-transfected cells and in the phorbol ester-treated cells, dephosphorylation of AUF1 p40, is associated with decreased AUF1 activity. In the case of PTH mRNA, inactivity of AUF1 results in a less stable PTH mRNA after expression of the CaR, as AUF1 is a PTH mRNA stabilizing protein [18,27].
###end p 35
###begin p 36
###xml 75 77 75 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 78 80 78 80 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 186 188 186 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 189 191 189 191 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 344 346 344 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 347 348 347 348 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o</sub>
###xml 498 500 498 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 501 503 501 503 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 799 800 799 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1166 1168 1166 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1169 1171 1169 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 1404 1406 1404 1406 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1407 1409 1407 1409 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 1427 1429 1427 1429 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1430 1431 1430 1431 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o</sub>
###xml 1474 1476 1474 1476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1477 1479 1477 1479 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 1589 1591 1589 1591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1592 1594 1592 1594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1617 1619 1617 1619 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 1620 1622 1620 1622 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 1708 1710 1708 1710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 1789 1791 1789 1791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1833 1841 1833 1841 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 1842 1844 1842 1844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 2187 2195 2187 2195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 2251 2252 2251 2252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 2253 2255 2253 2255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 2256 2258 2256 2258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 2259 2261 2259 2261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 2262 2264 2262 2264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 2510 2512 2510 2512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 2513 2514 2513 2514 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o</sub>
###xml 2198 2202 <span type="species:ncbi:10090">mice</span>
###xml 2207 2210 <span type="species:ncbi:9606">men</span>
We also show that expression of the CaR conferred responsiveness to low [Ca2+]o and the calcimimetic R568, underlining the relevance of this cellular model to the parathyroid. A low- [Ca2+]o medium increased PTH expression only in the cells expressing the CaR. Similarly, R568 decreased PTH expression through the CaR at both 1.2 and 0.2 mM [Ca2+]o. Therefore, regulation of PTH mRNA levels by expression of the CaR itself and both its activation by the calcimimetic and its relaxation by a low [Ca2+]o are maintained in these transfected cells. This is the first demonstration that the CaR can regulate PTH gene expression in heterologous cells. This regulation is obtained through the post-transcriptional mechanisms that involve changes in PTH mRNA-protein interactions in the parathyroid (Table 1). It is likely that PTH secretion would exhibit a similar regulation by calcium as PTH mRNA levels, given its dependence on the latter. However, secretion was not measured as a function of the extracellular calcium concentration in the heterologous HEK293 cell system, in which there is a prominent component of constitutive secretion, unlike the parathyroid cell [37,38]. Secretion in HEK293 cells may be independently regulated by the CaR although we have not studied this question. The parathyroid cell is unique in that the stimulus for secretion, gene expression and cell proliferation is a low [Ca2+]o and not a high [Ca2+]o. Inverse control of secretion by a low [Ca2+]o of PTHrP secretion also occurs in the epithelial cells of the lactating breast and certain breast cell lines [39,40]. In addition high [Ca2+]o decreases hormone secretion in the secretion of renin by renal juxtaglomerular cells [41]. Calcium receptor activation increases cell proliferation in cultured cells [42], but inhibits parathyroid proliferation in vivo [43]. It is remarkable and intriguing that despite these differences, the transfected cell system retains so many of the native characteristics of the unique parathyroid cell, specifically the relationship between calcium and PTH mRNA stability. The CaR-mediated decrease in PTH expression in these cells mirrors the marked increase in serum PTH in vivo in mice and men with inactivating mutations of the CaR [6,10,36,43,44]. These results support the concept that the parathyroid cell is geared to constitutively synthesize and secrete PTH, and it is the presence of a functioning CaR that tonically inhibits PTH expression and secretion and allows responsivity to [Ca2+]o.
###end p 36
###begin p 37
###xml 104 107 <span type="species:ncbi:10116">rat</span>
Regulation of PTH gene expression in HEK293 cells transfected with the CaR and hPTH plasmids and in the rat parathyroid by calcium
###end p 37
###begin p 38
AUF1 = AU rich binding factor; KSRP = KH domain splicing regulatory protein; PTH = parathyroid hormone
###end p 38
###begin title 39
Conclusion
###end title 39
###begin p 40
###xml 179 181 179 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 182 184 182 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink">o </sub>
###xml 315 320 315 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 389 397 389 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
The expression of the CaR in transfected HEK293 cells decreases PTH gene expression post-transcriptionally and is sufficient to confer the regulation of PTH gene expression by [Ca2+]o and a calcimimetic, R568. The CaR decreases PTH gene expression in these engineered cells through the balanced interactions of the trans-acting factors KSRP and AUF1 with PTH mRNA and the PTH mRNA ARE, as in vivo in the parathyroid. This is the first demonstration that the CaR can regulate PTH gene expression in heterologous transiently transfected cells.
###end p 40
###begin title 41
Methods
###end title 41
###begin title 42
Cells and transfection
###end title 42
###begin p 43
###xml 674 676 673 675 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 713 715 712 714 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 725 727 724 726 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 419 425 <span type="species:ncbi:9913">Bovine</span>
HEK293 cells were transiently co-transfected in a 10 cm dish with 5 mug expression plasmids for the PTH gene and the CaR plasmid or a control plasmid using a Calcium Phosphate Transfection Kit (Sigma, St Louis, MO, USA). At 48 h the cells expressing the CaR or controls were detached and replated in 24 well plates and treated as indicated, in triplicates for 48 h. Cells were grown in DMEM supplemented with 10% Fetal Bovine Serum (Biological Industries, Beit Haemek, Israel), L-Glutamine (Biological Industries, Beit Haemek, Israel) and Pen-Strep solution (Biological Industries, Beit Haemek, Israel). Calcium concentration in the medium was 1.2 mM. In some experiments Ca2+-free DMEM medium was used (0.2 mM Ca2+) and CaCl2 was added as indicated. R568, a gift from Amgen (Thousand Oaks, CA, USA) was dissolved in DDW and added to the medium at a final concentration of 1 muM.
###end p 43
###begin title 44
RNA extraction and analysis
###end title 44
###begin p 45
RNA extraction was performed using Tri reagent (Molecular Research Center, Cincinnati, OH, USA). mRNA concentration was determined using a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies; Wilmington, DE, USA). For real-time PCR 1 mug mRNA was used as template for RT PCR with Maxime RT PreMix (Random primer) from iNtRON (Gyeonggi-do, Korea). qPCR was performed using SYBR Green ROX Mix (ABgene, Surrey, UK) according to the manufacturer's instructions in 7900HT Fast Real-Time PCR Systems from Applied Biosystems.
###end p 45
###begin p 46
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
The following primers were used: hPTH (5'-gggtctgcagtccaattcat-3' and 5'-cagatttcccatccgatttt-3'), hGH (5'-gggaggctggaagatggc-3' and 5'-cgttgtgtgagtttgtgtcgaac-3'), hHPRT (5' tttgaatcatgtttgtgtcattagtga and 5' ttccaaactcaacttgaactctcatc). For Northern analysis RNA was run on agarose formaldehyde gels and blotted using a Hybond-N membrane (Amersham Biosciences, Little Chalfont, UK). Membranes were hybridized to fragments for hPTH or GFP [20,29]. In some experiments ethidium bromide staining of membranes was used for quantification of 18S or 28S as loading controls.
###end p 46
###begin title 47
Plasmids
###end title 47
###begin p 48
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hpa</italic>
###xml 132 134 132 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 167 170 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
For the hPTH expression plasmid, a HpaII fragment including the three exons and two introns of the hPTH gene from plasmid pPTHg108 [20] was inserted downstream of the CMV promoter in pcDNA3 expression plasmid (Invitrogen, San Diego, CA, USA). The hCaR plasmid was kindly provided by M Lohse (Wurzburg, Germany), the GFP pEGFP-C1 (Clontech, Palo Alto, CA, USA) and hGH (kindly provided by O Meyuhas, Jerusalem, Israel [45]) were used as controls. The GH-PTH63 or GH-tPTH40 expression plasmids contained 63 bp or a truncated 40 bp fragments of the PTH mRNA 3'-UTR ARE that were inserted between the coding region and the 3'-UTR of GH mRNA [29]. hPTH1R was provided by MA Levine, Cleveland, OH, USA). In some experiments cells co-transfected with the GFP plasmid were analyzed by fluorescent microscopy to estimate transfection efficiency, which was always >90%.
###end p 48
###begin title 49
Immunoreactive parathyroid hormone
###end title 49
###begin p 50
Medium was replaced 1 h prior to collection and analyzed using the Immulite 2000 Intact PTH assay (Los Angeles, CA, USA)
###end p 50
###begin title 51
In Vitro Degradation Assays
###end title 51
###begin p 52
###xml 183 184 181 182 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 356 358 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
Radiolabeled transcripts (200,000 cpm) were incubated with 40 mug protein extract from cells in a volume of 50 mul and in a reaction buffer containing 3 mM Tris HCl, pH 7.5, 2 mM MgCl2, 3 mM NaCl, 10 mM ATP and 30 units RNasin. At timed intervals samples were removed, RNA extracted, separated on agarose gels and analyzed by autoradiography as described [15].
###end p 52
###begin p 53
###xml 256 265 256 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 338 341 338 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sma</italic>
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 129 132 <span type="species:ncbi:10116">rat</span>
The following plasmids were used as templates for RNA transcription: pBluescript II KS plasmid containing either the full-length rat PTH cDNA (772 bp) or a PTH cDNA with an internal deletion of the PTH mRNA ARE and a stretch of ~150 dT nucleotides that by in vitro transcription produced a poly(A) tail. The plasmids were linearized with SmaI [20].
###end p 53
###begin title 54
2D gel electrophoresis
###end title 54
###begin p 55
###xml 48 50 48 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
Analysis was performed as previously described [27].
###end p 55
###begin title 56
RNA immunoprecipitation
###end title 56
###begin p 57
Transiently transfected cells were grown in a 14 cm dish for 48 h, collected in ice-cold PBS, pelleted and re-suspended in RIPA buffer (containing 150 mM NaCl, 1% NP40, 0.5% sodium deoxycholate, 0.1% SDS and protease inhibitors) supplemented with RNase inhibitors (Promega, Madison, WI, USA) and homogenized by pipetting. Equal amounts of whole cell extracts were immunoprecipitated with Protein A agarose-bound anti-KSRP or AUF1 antibody beads (Calbiochem, Darmstadt, Germany) or IgG as control after incubation for 2 hr at 4degreesC. The beads were then washed with modified RIPA buffer (supplemented with 1 M NaCl, 1% Sodium Deoxycholate, 1 mM EDTA and 2 M urea). RNA was extracted and analyzed by qPCR for PTH and GH mRNA using SYBR Green ROX Mix as described above.
###end p 57
###begin title 58
Intact cell enzyme-linked immunoassay
###end title 58
###begin p 59
###xml 49 51 49 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
The assay was performed as previously described [27]. In brief: 48 h after transfection cells were detached in PBS supplemented with BSA and EDTA. The cells were then pelleted and incubated for 1 h at 4degreesC with the anti-CaR antibody followed by PBS wash (x 3) and incubation with the secondary HRP-conjugated antibody. Cells were then washed (x 3) prior to adding the HRP substrate and the fluorescent signal was visualized using an electrochemiluminescent reader.
###end p 59
###begin title 60
Antibodies
###end title 60
###begin p 61
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">myc </italic>
Anti-KSRP was a gift from R Gherzi, Genoa, Italy. Anti-AUF was from Upstate (Charlottesville, VA, USA). Anti-myc was from Cell Signaling (Boston, MA, USA). Anti-CaR was from Abcam (Cambridge, UK).
###end p 61
###begin title 62
Statistics
###end title 62
###begin p 63
###xml 182 183 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">T</italic>
###xml 246 248 244 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Statistical analysis was performed using Microsoft Excel (Microsoft Corporation, Redmond, WA, USA). Values are reported as mean +/- SEM unless stated otherwise. A 2-tailed Student's T-test was used to assess differences from the control group. A P value of less than 0.05 was considered significant.
###end p 63
###begin title 64
Abbreviations
###end title 64
###begin p 65
###xml 202 211 202 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 80 84 <span type="species:ncbi:9913">calf</span>
###xml 146 151 <span type="species:ncbi:9606">human</span>
ARE: AU-rich element; AUF1: AU rich binding factor; CaR: calcium receptor; CIP: calf intestinal phosphatase; GFP: green fluorescent protein; HEK: human embryonic kidney; HPT: hyperparathyroidism; IVDA: in vitro degradation assay; KSRP: KH domain splicing regulatory protein; PTH: parathyroid hormone; qRT PCR: quantitative reverse transcriptase polymerase chain reaction; RIP: RNA immunoprecipitation; TM: transmembrane; UTR: untranslated region.
###end p 65
###begin title 66
Authors' contributions
###end title 66
###begin p 67
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C&#8211;D</xref>
Most experiments were performed by HG who also conceived and designed the experiments. VL-M performed the experiments in Fig 4C-D and MN and TM assisted in different experiments. JS and TN-M conceived, designed and wrote the manuscript. All authors read and approved the final manuscript.
###end p 67
###begin title 68
Acknowledgements
###end title 68
###begin p 69
This work was supported in part by the American Society of Bone and Mineral Research Bridging Fund and grants from the Israel Academy of Sciences and Amgen.
###end p 69
###begin article-title 70
###xml 51 53 51 53 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 76 82 <span type="species:ncbi:9913">bovine</span>
Cloning and characterization of an extracellular Ca2+-sensing receptor from bovine parathyroid
###end article-title 70
###begin article-title 71
Parathyroid hormone: molecular biology
###end article-title 71
###begin article-title 72
The calcium-sensing receptor: a key factor in the pathogenesis of secondary hyperparathyroidism
###end article-title 72
###begin article-title 73
Extracellular calcium sensing and signalling
###end article-title 73
###begin article-title 74
Calcimimetics with potent and selective activity on the parathyroid calcium receptor
###end article-title 74
###begin article-title 75
Naturally occurring mutations of the extracellular Ca2+-sensing receptor: implications for its structure and function
###end article-title 75
###begin article-title 76
Increased parathyroid hormone gene expression in secondary hyperparathyroidism of experimental uremia is reversed by calcimimetics: correlation with posttranslational modification of the trans acting factor AUF1
###end article-title 76
###begin article-title 77
###xml 55 58 <span type="species:ncbi:10116">rat</span>
Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism
###end article-title 77
###begin article-title 78
Parathyroid-specific double knockout of Gq and G11 alpha-subunits leads to a phenotype resembling germline knockout of the extracellular Ca2+ -sensing receptor
###end article-title 78
###begin article-title 79
###xml 2 7 <span type="species:ncbi:10090">mouse</span>
###xml 17 22 <span type="species:ncbi:9606">human</span>
A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism
###end article-title 79
###begin article-title 80
The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone
###end article-title 80
###begin article-title 81
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Rescue of the skeletal phenotype in CasR-deficient mice by transfer onto the Gcm2 null background
###end article-title 81
###begin article-title 82
Mechanisms of secondary hyperparathyroidism
###end article-title 82
###begin article-title 83
###xml 56 60 <span type="species:ncbi:10116">rats</span>
Parathyroid hormone gene expression in hypophosphatemic rats
###end article-title 83
###begin article-title 84
RNA protein binding and post-transcriptional regulation of PTH gene expression by calcium and phosphate
###end article-title 84
###begin article-title 85
A conserved cis-acting element in the parathyroid hormone 3'-untranslated region is sufficient for regulation of RNA stability by calcium and phosphate
###end article-title 85
###begin article-title 86
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis </italic>
###xml 67 72 <span type="species:ncbi:9606">human</span>
###xml 77 83 <span type="species:ncbi:9913">bovine</span>
Identification and characterization of cis -acting elements in the human and bovine parathyroid hormone mRNA 3'-untranslated region
###end article-title 86
###begin article-title 87
Identification of AUF1 as a parathyroid hormone mRNA 3'-untranslated region binding protein that determines parathyroid hormone mRNA stability
###end article-title 87
###begin article-title 88
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
In vitro evidence that upstream of N-ras participates in the regulation of parathyroid hormone messenger ribonucleic acid stability
###end article-title 88
###begin article-title 89
The mRNA decay promoting factor K-homology splicing regulator protein post-transcriptionally determines parathyroid hormone mRNA levels
###end article-title 89
###begin article-title 90
###xml 53 59 <span type="species:ncbi:9913">bovine</span>
Effects of the calcium ionophore A23187 on dispersed bovine parathyroid cells
###end article-title 90
###begin article-title 91
###xml 72 75 <span type="species:ncbi:10116">rat</span>
Direct effect of phosphorus on parathyroid hormone secretion from whole rat parathyroid glands in vitro
###end article-title 91
###begin article-title 92
###xml 108 114 <span type="species:ncbi:9913">bovine</span>
Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells
###end article-title 92
###begin article-title 93
###xml 84 90 <span type="species:ncbi:9913">bovine</span>
Regulation of parathyroid hormone messenger RNA levels by protein kinase A and C in bovine parathyroid cells
###end article-title 93
###begin article-title 94
###xml 73 79 <span type="species:ncbi:9913">bovine</span>
###xml 113 118 <span type="species:ncbi:9606">human</span>
The Ca2+-sensing receptor (CaR) activates phospholipases C, A2, and D in bovine parathyroid and CaR-transfected, human embryonic kidney (HEK293) cells
###end article-title 94
###begin article-title 95
###xml 56 62 <span type="species:ncbi:9913">bovine</span>
Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells
###end article-title 95
###begin article-title 96
The protein phosphatase calcineurin determines basal parathyroid hormone gene expression
###end article-title 96
###begin article-title 97
###xml 29 34 <span type="species:ncbi:9606">human</span>
The carboxyl terminus of the human calcium receptor. Requirements for cell-surface expression and signal transduction
###end article-title 97
###begin article-title 98
The parathyroid hormone mRNA 3'-untranslated region AU-rich element is an unstructured functional element
###end article-title 98
###begin article-title 99
###xml 3 12 3 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
An in vitro assay to study regulated mRNA stability
###end article-title 99
###begin article-title 100
Regulation of A + U-rich element-directed mRNA turnover involving reversible phosphorylation of AUF1
###end article-title 100
###begin article-title 101
Phosphorylation of p40AUF1 regulates binding to A + U-rich mRNA-destabilizing elements and protein-induced changes in ribonucleoprotein structure
###end article-title 101
###begin article-title 102
###xml 43 49 <span type="species:ncbi:9913">bovine</span>
Loss of calcium responsiveness in cultured bovine parathyroid cells is associated with decreased calcium receptor expression
###end article-title 102
###begin article-title 103
Parathyroid cells cultured in collagen matrix retain calcium responsiveness: importance of three-dimensional tissue architecture
###end article-title 103
###begin article-title 104
Destabilization of parathyroid hormone mRNA by extracellular Ca2+ and the calcimimetic R-568 in parathyroid cells: role of cytosolic Ca and requirement for gene transcription
###end article-title 104
###begin article-title 105
###xml 79 84 <span type="species:ncbi:9606">human</span>
Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells
###end article-title 105
###begin article-title 106
Genetically engineered proinsulin constitutively processed and secreted as mature, active insulin
###end article-title 106
###begin article-title 107
Expression of regulated secretory proteins is sufficient to generate granule-like structures in constitutively secreting cells
###end article-title 107
###begin article-title 108
Switching of G-protein usage by the calcium-sensing receptor reverses its effect on parathyroid hormone-related protein secretion in normal versus malignant breast cells
###end article-title 108
###begin article-title 109
The calcium-sensing receptor regulates mammary gland parathyroid hormone-related protein production and calcium transport
###end article-title 109
###begin article-title 110
Expression and function of the calcium-sensing receptor in juxtaglomerular cells
###end article-title 110
###begin article-title 111
###xml 40 43 <span type="species:ncbi:10116">rat</span>
Functional calcium-sensing receptors in rat fibroblasts are required for activation of SRC kinase and mitogen-activated protein kinase in response to extracellular calcium
###end article-title 111
###begin article-title 112
###xml 25 28 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+ </sup>
###xml 17 22 <span type="species:ncbi:9606">human</span>
Mutations in the human Ca2+ -sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism
###end article-title 112
###begin article-title 113
A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor [see comments]
###end article-title 113
###begin article-title 114
Oligopyrimidine tract at the 5' end of mammalian ribosomal protein mRNAs is required for their translational control
###end article-title 114

